Probiotic sales defeat EFSA's blow
Consumer demand is sustaining probiotics sales, despite the blow of the European Food Safety Authority's (EFSA's) health claims rejections, say some of industry's main players.
Archives for July 15, 2012
USPLabs promises new data that ‘definitively’ proves presence of DMAA in geranium
USPLabs has challenged the findings of new research on the source of DMAA and alerted the trade to the imminent publication of data it claims “definitively demonstrates” that the much-maligned stimulant is naturally present in the geranium plant.
DMAA in the dock
Australian medicines agency adds DMAA to poisons list
Australia’s medicines regulator – the Therapeutic Goods Administration (TGA) - has added DMAA to its Schedule 9 list of prohibited substances and poisons that includes cannabis, salvia divinorum, GHB, heroin, psilocybin and LSD.
AHPA committed to GMP compliance, but learning curve was expected: McGuffin to Durbin staff
The learning curve for GMP compliance is to be expected – just look at other FDA-regulated industries, Michael McGuffin, president The American Herbal Products Association (AHPA), told staff for Senator Dick Durbin in a meeting July 13.
FDA files injunction against NY supplements company for GMP violations
The US Food and Drug Administration (FDA) has again shown that it will go beyond just sending warning letters for GMP violations after filing an injunction against a NY supplement manufacturer.
NPA slams ‘needlessly scary’ Archives of Internal Medicine commentary
A commentary in the American Medical Association’s journal the Archives of Internal Medicine may needlessly scare people into not taking products they use to support their health, says the Natural Products Association (NPA).
New UK supplier enters ingredients game with health claim answers
LPC Group is driving its ingredients business toward food supplements and functional foods in a move designed to leverage its “heritage” in the personal care and pharma sectors.